Ren Guo

1.2k total citations
62 papers, 922 citations indexed

About

Ren Guo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ren Guo has authored 62 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Immunology and 13 papers in Cancer Research. Recurrent topics in Ren Guo's work include Atherosclerosis and Cardiovascular Diseases (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ren Guo is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ren Guo collaborates with scholars based in China, United States and Czechia. Ren Guo's co-authors include Tian Wu, Bikui Zhang, Heng Yang, Dai Li, Xin Guo, Zhi Song, Ding Liu, Xiangdong Peng, Yuan‐Jian Li and Min Chen and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Ren Guo

56 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren Guo China 19 291 148 145 139 120 62 922
Minmin Zhu China 21 496 1.7× 160 1.1× 216 1.5× 170 1.2× 104 0.9× 52 1.2k
Bin Kong China 20 368 1.3× 128 0.9× 78 0.5× 57 0.4× 80 0.7× 62 968
Yasushi Ueno Japan 13 356 1.2× 124 0.8× 84 0.6× 55 0.4× 291 2.4× 63 1.1k
Xudong Wang China 18 385 1.3× 85 0.6× 167 1.2× 79 0.6× 68 0.6× 59 1.1k
Wenhua Yu China 25 585 2.0× 167 1.1× 138 1.0× 53 0.4× 285 2.4× 76 1.5k
Xiao‐Qiao Dong China 24 567 1.9× 170 1.1× 124 0.9× 55 0.4× 340 2.8× 82 1.4k
Honglian Wang China 21 676 2.3× 148 1.0× 203 1.4× 49 0.4× 95 0.8× 73 1.3k
Nuno Pires Portugal 19 296 1.0× 198 1.3× 87 0.6× 219 1.6× 82 0.7× 51 1.2k
Rodica Bălașa Romania 16 276 0.9× 137 0.9× 78 0.5× 55 0.4× 116 1.0× 111 1.0k

Countries citing papers authored by Ren Guo

Since Specialization
Citations

This map shows the geographic impact of Ren Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Guo more than expected).

Fields of papers citing papers by Ren Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Guo. The network helps show where Ren Guo may publish in the future.

Co-authorship network of co-authors of Ren Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Guo. A scholar is included among the top collaborators of Ren Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Guo. Ren Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Youjie, Ren Guo, Songhua Chen, et al.. (2025). Inhibition of diacylglycerol O-acyltransferase 1 provides neuroprotection by inhibiting ferroptosis in ischemic stroke. Molecular Medicine. 31(1). 191–191. 1 indexed citations
2.
Wang, Xia, et al.. (2024). PF-477736 modulates vascular smooth muscle cells phenotypic transition through Chk1/p53/CD44 pathway. Tissue and Cell. 93. 102682–102682.
3.
Yan, Xin, Jun Huang, Youjie Zeng, et al.. (2024). CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFκB pathway in pulmonary arterial hypertension. Biochemical Pharmacology. 222. 116093–116093. 9 indexed citations
4.
Wei, Ning, Ge Gao, Yong Zhou, et al.. (2023). Bazedoxifene attenuates intestinal injury in sepsis by suppressing the NF-κB/NLRP3 signaling pathways. European Journal of Pharmacology. 947. 175681–175681. 8 indexed citations
5.
Wei, Ning, Yong Zhou, Wenqun Li, et al.. (2023). Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation. International Immunopharmacology. 116. 109747–109747. 12 indexed citations
6.
Xiao, Haiyan, Tao Song, Youjie Zeng, et al.. (2023). HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma. Journal of Cancer Research and Clinical Oncology. 149(16). 14911–14926. 3 indexed citations
7.
Zeng, Youjie, et al.. (2023). Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis. Frontiers in Genetics. 14. 1058582–1058582. 2 indexed citations
8.
Gao, Kai, et al.. (2020). Bazedoxifene inhibits PDGF-BB induced VSMC phenotypic switch via regulating the autophagy level. Life Sciences. 259. 118397–118397. 13 indexed citations
9.
Guo, Ren, et al.. (2019). Effects of Myeloperoxidase on Methicillin-Resistant Staphylococcus aureus- Colonized Burn Wounds in Rats. Advances in Wound Care. 8(7). 271–280. 1 indexed citations
10.
Guan, Xiaofeng, Qingjie Chen, Xiao‐cong Zuo, et al.. (2016). Contrast Media-Induced Renal Inflammation Is Mediated Through HMGB1 and Its Receptors in Human Tubular Cells. DNA and Cell Biology. 36(1). 67–76. 25 indexed citations
11.
Guo, Xin, Dai Li, Min Chen, et al.. (2016). miRNA-145 inhibits VSMC proliferation by targeting CD40. Scientific Reports. 6(1). 35302–35302. 53 indexed citations
12.
Guo, Ren, et al.. (2015). The role of CGRP and CALCA T-692C single-nucleotide polymorphism in psoriasis vulgaris.. PubMed. 70(2). 88–93. 11 indexed citations
13.
Dang, Ruili, Pei Jiang, Hualin Cai, et al.. (2015). Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: Involvement of the INSIG/SREBP pathway. European Neuropsychopharmacology. 25(8). 1239–1247. 26 indexed citations
14.
Yang, Heng, Ren Guo, Yufeng Peng, et al.. (2013). The Antiepileptic Effect of the Glycolytic Inhibitor 2-Deoxy-d-Glucose is Mediated by Upregulation of KATP Channel Subunits Kir6.1 and Kir6.2. Neurochemical Research. 38(4). 677–685. 30 indexed citations
15.
Zhang, Bikui, et al.. (2013). Association of CD40 −1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population. International Immunopharmacology. 16(4). 461–465. 30 indexed citations
16.
Zhang, Bikui, et al.. (2013). The CD40/CD40L system: A new therapeutic target for disease. Immunology Letters. 153(1-2). 58–61. 66 indexed citations
17.
Guo, Ren, Xiaoping Chen, Xin Guo, et al.. (2008). Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response and Association With Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys Polymorphism. Journal of the American College of Cardiology. 52(11). 953–960. 17 indexed citations
18.
Xiao, Hong‐Bo, Zhi‐Chun Yang, Sujie Jia, et al.. (2007). Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice. Life Sciences. 81(1). 1–7. 15 indexed citations
19.
Dai, Li, Nian‐Sheng Li, Qingquan Chen, et al.. (2007). Calcitonin gene-related peptide-mediated cardioprotection of postconditioning in isolated rat hearts. Regulatory Peptides. 147(1-3). 4–8. 25 indexed citations
20.
Liu, Hongyan, et al.. (1999). Cloning expression and purification of human interleukin-6. 25(1). 14–15. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026